
- AN-2728
- Cilomilast
- GSK256066
- Rolipram
- CDP 840 hydrochloride
Apremilast (CC-10004)PDE4 inhibitor |
Sample solution is provided at 25 µL, 10mM.
































Quality Control & MSDS
- View current batch:
- Purity = 98.98%
- COA (Certificate Of Analysis)
- HPLC(Retest)
- NMR (Nuclear Magnetic Resonance)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure

Description | Apremilast(CC10004) is a novel small-molecule inhibitor of PDE4 with an IC50 value of 74 nM. | |||||
Targets | PDE4 | |||||
IC50 | 74 nM |
Cell experiment [1]: | |
Cell lines | U937 human monocytic cells |
Preparation method | The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. |
Reaction Conditions | 18h; IC50=74 nM |
Applications | Apremilast was initially screened for PDE4 inhibition using a partially purified enzyme preparation from U937 human monocytic cells and which has been shown previously to contain predominantly PDE4B and PDE4D activities. Apremilast was also found to exhibit an IC50 of around 74 nM using 1 mM cAMP as substrate. |
Animal experiment [1]: | |
Animal models | SCID mice |
Dosage form | 5 mg·kg-1·day-1 ; oral taken |
Applications | The pharmacological activity of apremilast (5 mg·kg-1·day-1 total divided into 2 daily doses) was tested in comparison with cyclosporine (5 mg·kg-1·day-1 total divided into 2 daily doses) and vehicle control (0.1 mL·day-1 divided into twice daily doses) in a mouse xenograft model of psoriasis. Epidermal thickness and proliferation index correlated with histological findings and demonstrated significant differences between treatment groups. Notably, apremilast caused statistically significant reductions in epidermal thickness (P < 0.001)="" and="" proliferation="" index="" (p=""><> |
Other notes | Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
References: [1] Schafer P H, Parton A, Gandhi A K, et al. Apremilast, a cAMP phosphodiesterase‐4 inhibitor, demonstrates anti‐inflammatory activity in vitro and in a model of psoriasis[J]. British journal of pharmacology, 2010, 159(4): 842-855. |

Apremilast (CC-10004) Dilution Calculator
calculate

Apremilast (CC-10004) Molarity Calculator
calculate
Cas No. | 608141-41-9 | SDF | Download SDF |
Synonyms | N/A | ||
Chemical Name | N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide | ||
Canonical SMILES | CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC | ||
Formula | C22H24N2O7S | M.Wt | 460.5 |
Solubility | ≥23.05 mg/mL in DMSO, <2.51 mg/ml="" in="" etoh,="">2.51><2.43 mg/ml="" in="" h2o="">2.43> | Storage | Store at -20°C |
Physical Appearance | A solid | Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
Apremilast, also known as CC-10004, is a novel and potent small-molecule inhibitor of phosphodiesterase 4 (PDE4), a key enzyme involved in cyclic adenosine monophosphate (cAMP) degradation and cytokine production of inflammatory cells. Apremilast binds to the catalytic site of PDE4, with values of inhibition constant IC50 and affinity constant Kiof 0.074 μM and 68 nM respectively, consequently leading to the degradation of cAMP. Apremilast exhibits anti-inflammatory activities against inflammatory disease in animal models as well as human chronic inflammatory diseases (such as psoriasis and psoriatic arthritis) by blocking the synthesis of a range of pro-flammatory cytokines and chemokines, including tumor necrosis factor alpha, interleukin 23, CXCL9 and CXCL10.
Reference
Georg Schett, Victor S. Sloan, Randall M. Stevens and Peter Schafer. Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory disease. Ther Adv Musculoskelet Dis. 2010; 2(5): 271-278
ebiomall.com






>
>
>
>
>
>
>
>
>
引物,又名引子。是一小段单链DNA或RNA,作为DNA复制的起始点,在核酸合成反应时,作为每个多核苷酸链进行延伸的出发点而起作用的多核苷酸链,之所以需要引物是因为在DNA合成中DNA聚合酶仅仅可以把新的核苷酸加到已有的DNA链上。
看引物能不能特异性扩增,你可以检查一下扩增后的熔解曲线,一般单一的峰是特异性引物,如果有双峰那就是扩出来了杂带
一般来讲,进行real-time qPCR MasterMix都是2×的浓缩液,只需要加入模板和引物就可以。由于real-time qPCR灵敏度高,所以每个样品至少要做3个平行孔,以防在后面的数据分析中,由于Ct相差较多或者SD太大,无法进行统计分析。通常来讲,反应体系的引 物终浓度为100-400mM;模板如果是总RNA一般是10ng-500,如果cDNA,通常情况下是1ul或者1ul的10倍稀释液,要根据目的基因 的表达丰度进行调整。当然这些都是经验值,在操作过程中,还需要根据所用MasterMix,模板和引物的不同进行优化,达到一个最佳反应体系。在反应体 系配置过程中,有下面几点需要注意:
1. MasterMix不要反复冻融,如果经常使用,最好溶解后放在4度。
2. 更多的配制Mix进行,减少加样误差。最好能在冰上操作。
3. 每管或每孔都要换新枪头!不要连续用同一个枪头加样!
4. 所有成分加完后,离心去除气泡。
5. 每个样品至少3个平行孔。
It is designed to address the challenge of pathogen detection, species identification and taxa discrimination using TaqMan and molecular beacon assays. With ClustalW multiple sequence alignment at its core, AlleleID can help design universal or taxa/species specific primers and probes. All major qPCR assays including molecular beacons, TaqMan, FRET or SYBR Green are supported. It uses BLAST search to assure specificity. To assure assay success, AlleleID uses template folding to avoid locating primers in the secondary structures of the template.
With AlleleID, you can avoid gDNA by designing primers/probes across exon/exon boundaries. The intron exon regions are identified by interpreting GenBank annotations or by specifying them manually.
To get started quickly with AlleleID, please download and listen to the multi-media tutorial:
http://www.PremierBiosoft.com/DATAFILES/AL100Tour.exe.
Then please download the demo version of the program from:
http://www.premierbiosoft.com/DATAFILES/AlleleIDTour.exe

